Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Emelissa J. Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Diagnostic Microbiology and Infectious Disease (2020) Vol. 99, Iss. 4, pp. 115294-115294
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
Julien Favresse, Constant Gillot, Laura Di Chiaro, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 90
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
Anton M. Sholukh, Andrew Fioré-Gartland, Emily S. Ford, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 10
Open Access | Times Cited: 86
Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
Niko Kohmer, Cornelia Rühl, Sandra Ciesek, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2128-2128
Open Access | Times Cited: 60
Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
Natalie Hofmann, Marica Grossegesse, Markus Neumann, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 39
Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference
Marianne Graninger, Claudia Jani, Elisabeth Reuberger, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Severe Acute Respiratory Syndrome Coronavirus‐2
Patricia Slev
(2024), pp. 572-582
Closed Access | Times Cited: 8
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort
Alexandra Rockstroh, Johannes Wolf, Jasmin Fertey, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 774-781
Open Access | Times Cited: 45
Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay
Jesse Papenburg, Matthew P. Cheng, Rachel Corsini, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 42
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
Diego Cantoni, Craig Wilkie, Emma M. Bentley, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort
Constant Gillot, Julien Favresse, Clara David, et al.
Microbiology Research (2024) Vol. 15, Iss. 1, pp. 422-430
Open Access | Times Cited: 5
Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
Abigail Lamikanra, Dung Nguyen, Peter Simmonds, et al.
Transfusion (2021) Vol. 61, Iss. 10, pp. 2837-2843
Open Access | Times Cited: 33
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
Carlos A. Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Viruses (2021) Vol. 13, Iss. 10, pp. 1972-1972
Open Access | Times Cited: 32
Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay
Minjeong Nam, Jong Do Seo, Hee‐Won Moon, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 29
Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
Václav Šimánek, Ladislav Pecen, Zuzana Krátká, et al.
Diagnostics (2021) Vol. 11, Iss. 4, pp. 593-593
Open Access | Times Cited: 28
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
Poramed Winichakoon, Jiraprapa Wipasa, Kriangkrai Chawansuntati, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 10
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management
Ronald von Possel, Babett Menge, Christina Deschermeier, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 91-91
Open Access | Times Cited: 3
Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy
Zhangkai J. Cheng, Bizhou Li, Zhiqing Zhan, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 64, Iss. 1, pp. 17-32
Open Access | Times Cited: 16
Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD
Denis Kolesov, Maria V. Sinegubova, Lutsia K. Dayanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 393-393
Open Access | Times Cited: 16
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Claire Mullender, Kelly A. S. da Costa, Aljawharah Alrubayyi, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
Emelissa J. Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 21
Evaluation of the correlation between the access SARS‐CoV‐2 IgM and IgG II antibody tests with the SARS‐CoV‐2 surrogate virus neutralization test
Yutaro Kitagawa, Kazuo Imai, Masaru Matsuoka, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 335-341
Open Access | Times Cited: 20
Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population
Hee-Jung Lee, Jin Jung, Ji Hyun Lee, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 946-946
Open Access | Times Cited: 15
Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
Tatjana Vilibić‐Čavlek, Maja Bogdanić, Ema Borko, et al.
Antibodies (2023) Vol. 12, Iss. 2, pp. 35-35
Open Access | Times Cited: 8
The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus Neutralization Test Method
Agnes Rengga Indrati, Erinca Horian, Nina Susana Dewi, et al.
Diagnostics (2024) Vol. 14, Iss. 16, pp. 1776-1776
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top